Finance

Lists
524715:BOM
Sun Pharmaceutical Industries Ltd
₹ 1,760.60
+0.67%
(+11.70) 1D
10-р сарын 15, 15:30:00 (GMT+5:30)  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 524715...
Open
₹ 1,730.00
High
₹ 1,777.40
Low
₹ 1,730.00
Mkt. cap
4.23ИН
Avg. vol.
103.70 мян
Volume
77.49 мян
Dividend
0.91%
Quarterly dividend
₹ 4.00
Ex-dividend date
2026 оны 7-р сарын 7
P/E ratio
34.90
52-wk high
₹ 2,047.55
52-wk low
₹ 1,583.60
EPS
₹ 50.44
Shares outstanding
0.00
No. of employees
47 мян
Open
₹ 1,730.00
High
₹ 1,777.40
Low
₹ 1,730.00
Mkt. cap
4.23ИН
Avg. vol.
103.70 мян
Volume
77.49 мян
Dividend
0.91%
Quarterly dividend
₹ 4.00
Ex-dividend date
2026 оны 7-р сарын 7
P/E ratio
34.90
52-wk high
₹ 2,047.55
52-wk low
₹ 1,583.60
EPS
₹ 50.44
Shares outstanding
0.00
No. of employees
47 мян
News stories
From web sources and news partners
ad-hoc-news.de
ad-hoc-news.de
·
13 цагийн өмнө
Analyst consensus puts Sun Pharma stock at INR 2,180.00
Moneycontrol.com
Moneycontrol.com
·
1 өдрийн өмнө
Sun Pharma: Tariff relief, innovation brighten growth outlook
ad-hoc-news.de
ad-hoc-news.de
·
2 өдрийн өмнө
Geojit raises target for Sun Pharma stock to INR 2,070.00
Profile
Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. It manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients in more than 100 countries. It is the largest pharmaceutical company in India and the fourth largest specialty generic pharmaceutical company in the world. Around 70% of Sun Pharma’s revenue is generated from international markets. The US and India are the largest markets, accounting for over 60% of the company's turnover. Manufacturing is across 43 locations in India, the US, Asia, Africa, Australia and Europe. The products cater to therapeutic segments covering psychiatry, anti-infectives, neurology, cardiology, diabetology, gastroenterology, ophthalmology, nephrology, urology, dermatology, gynaecology, respiratory, oncology, dental and nutritionals. Its active pharmaceutical products include baricitinib, brivaracetam, and dapaglifozin. Wikipedia
About Sun Pharmaceutical Industries Ltd
CEO-
Employees47 мян
Founded1983
HeadquartersGoregaon East, Мумбай, Энэтхэг
SectorPharmaceutical industry
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
144.78Т
155.21Т
146.12Т
153.00Т
Cost of goods sold
29.83 тэрбум
29.45 тэрбум
37.36 тэрбум
29.63 тэрбум
Cost of revenue
29.83 тэрбум
29.45 тэрбум
37.36 тэрбум
29.63 тэрбум
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
27.65 тэрбум
28.92 тэрбум
30.60 тэрбум
32.27 тэрбум
Operating expense
81.28 тэрбум
85.13 тэрбум
80.66 тэрбум
87.80 тэрбум
Total operating expenses
111.11Т
114.58Т
118.02Т
117.43Т
Operating income
33.67 тэрбум
40.62 тэрбум
28.10 тэрбум
35.57 тэрбум
Other non operating income
4.70 тэрбум
5.79 тэрбум
-14.29 тэрбум
7.24 тэрбум
EBT including unusual items
41.55 тэрбум
42.07 тэрбум
35.37 тэрбум
40.89 тэрбум
EBT excluding unusual items
41.55 тэрбум
46.97 тэрбум
26.83 тэрбум
42.93 тэрбум
Income tax expense
10.31 тэрбум
8.26 тэрбум
8.28 тэрбум
11.88 тэрбум
Effective tax rate
24.80%
19.63%
23.40%
29.05%
Other operating expenses
46.34 тэрбум
48.89 тэрбум
42.30 тэрбум
48.14 тэрбум
Net income
31.18 тэрбум
33.69 тэрбум
27.14 тэрбум
28.95 тэрбум
Net profit margin
21.54%
21.71%
18.57%
18.92%
Earnings per share
13.00
15.48
11.30
12.71
Interest and investment income
-
-
9.74 тэрбум
-
Interest expense
-998.60 сая
-783.60 сая
-858.90 сая
-996.70 сая
Net interest expenses
-998.60 сая
-783.60 сая
8.89 тэрбум
-996.70 сая
Depreciation and amortization charges
7.30 тэрбум
7.32 тэрбум
7.75 тэрбум
7.39 тэрбум
EBITDA
40.82 тэрбум
46.53 тэрбум
34.86 тэрбум
42.32 тэрбум
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google аппс